Metabolomics Approach After Acute Intake of Grumixama Juice
13 giugno 2016 aggiornato da: Luciane de Lira Teixeira, University of Sao Paulo
Metabolomics Approach After Acute Intake of Grumixama Juice (Eugenia Brasiliensis Lam)
Investigate the bioavailability of the main flavonoid, their colonic transformation and untargeted metabolites by an metabolomic approach following acute intake of a grumixama juice by humans.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The grumixama is a sweet and little cherry native of the South and Southeast regions of the Atlantic Forest of Brazil rich in phenolic compounds, mainly anthocyanins and ellagitannins. The objective of this study is Investigate the bioavailability of the main flavonoid, their colonic transformation and untargeted metabolites by an metabolomic approach following acute intake of a grumixama juice by humans.
Fifteen healthy subjects consumed grumixama juice at single dose, and urine and plasma samples were collected at different time points over 24 h period. The metabolites were analyzed by LC-ESI-MSn, LC-Q-TOF plasma and urine were also analyzed using untargeted metabolomic approach for amino acids and organic acids by GCMS.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
15
Fase
- Non applicabile
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 18 anni a 49 anni (Adulto)
Accetta volontari sani
Sì
Sessi ammissibili allo studio
Femmina
Descrizione
Inclusion Criteria:
- Not have medical historical of cardiovascular, gastrointestinal, hepatic, renal, thyroid and/or diabetes dysfunction
- Not be alcohol addicts, not use vitamins and other supplements
- Not are using any kind of medication which affect the digestion and absorption of food, not be smokers
- Not are pregnant.
Exclusion Criteria:
- Have medical historical of cardiovascular, gastrointestinal, hepatic, renal, thyroid and/or diabetes dysfunction
- Be alcohol addicts, use vitamins and other supplements
- Are using any kind of medication which affect the digestion and absorption of food, be smokers
- Are pregnant.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Altro: Grumixama Juice
Juice of grumixama purple fruit (Eugenia brasiliensis Lam.), which is good source of anthocyanins and ellagitannins. It was made with filtered water and sanitized fruits, with a blender. It was administered in single dose of 0.97 mg of anthocyanins and of 4.71 mg of ellagitannins per mL of juice. Which volunteers ingested 10 mL of juice per each Kg body weight. The metabolomic approach of plasma and urine samples following acute intake of grumixama juice was done by the collection of blood samples and urine, following the intake of grumixama juice. |
In the morning of experimental day after 10 h fasting, the volunteers have been collect the first urine in the morning and it was collected the blood before the intake of grumixama juice, after they drink the juice (0 min), it was collected blood at the times: 15 min, 30 min, 60 min,120 min, 240 min and 24 h; and it was also collected urine at the period: 0 -1h, 1 - 2h, 2 - 4h, 4 - 6 h, 6 - 12 h, 12 - 14 h, the first urine in the morning in the second day (24 h).
During the period in the first 4 h of experiment the volunteers only intake the juice.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Identification of metabolites in plasma and urine samples of 15 healthy volunteers after intake of grumixama juice by LCMS
Lasso di tempo: 2 months
|
The blood and urine samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the anthocyanins and ellagitannins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by LC-ESI-MSn (for phenolic acids and anthocyanins) and LC-Q-TOF (for urolithins), the mass fragments were expressed in m/z.
|
2 months
|
|
Identification of metabolites in plasma and urine samples of 15 healthy volunteers after intake of grumixama juice by GCMS.
Lasso di tempo: 2 months
|
The samples were collected as describe in "Arms and Interventions", but for urine samples were used only the samples collected at times 0 (before the juice intake), 0-1h, 1-2h, 2-4h and at 24h after intake.
The plasma samples had their proteins precipitated with cold methanol, the metabolites were extracted, concentrated and the amino acids and organic acids were derivatized to became volatile and the samples were analyzed by GCMS.
For urine samples the procedures were similar.
The mass fragment profile of derivatized compounds were compared to a GCMS library.
|
2 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Urinary creatinine values of 15 healthy volunteers for data normalization
Lasso di tempo: 15 days
|
The creatinine was measured in the 15 volunteers by using a commercial kit, the results obtained in mg/dL, and these values were transformed in mol/L.
The values of creatinine were used to normalize the quantification data.
|
15 days
|
|
Cycle cell analysis in breast cancer cells treated with metabolites extracted from plasma and urine of 10 healthy volunteers after grumixama juice intake
Lasso di tempo: 2 days
|
Plasma and urine preparations were obtained by SPE extraction were dried and tested against breast cancer cells (MDA-MB 231) MDA-MB 231 cells were cultured in monolayer on Dulbecco Eagle modified culture medium supplemented with 10% fetal bovine serum, it was used 5x10-4 cells per well. The cells were incubated in a humidified chamber including 5% CO2 at 37ºC into a confluence of approximately 80%. Cells were further exposed to 200 mg/mL of urine and plasma extract preparations and phenolic compound standards (PCA, VA, HA, C3G) at 0.25 and 25 mg/mL, and maintained at 37ºC, under an atmosphere of 5% CO2 for 48 hours. Negative control was supplied with growth media and DMSO, and blank wells containing growth media only. The cells were lysed, the RNA were degraded and the DNA were marked with propidium iodide (1mg/mL) and the fluorescence was measure by flow cytometer and the cell cycle analysis were done by FlowJo. The results were expressed in % of cell for each cell cycle phase. |
2 days
|
|
Multivariate data analysis of metabolites identified in plasma and urine of 15 healthy volunteers after intake of grumixama juice by GCMS
Lasso di tempo: 2 months
|
The peak intensity of each compound identified by GCMS were normalized by using a internal standards (D4-alanine).
For urine these data also were normalized by creatinine values to normalize sample volume.
Multivariate data analysis were done observe changes in these metabolites (amino acids and organic acids) during the 24h after grumixama juice intake.
The data were analyzed by MetaboAnalyst 3.0 (http://www.metaboanalyst.ca/).
|
2 months
|
|
Pathway analysis of metabolites identified by GCMS
Lasso di tempo: 1 month
|
The samples were collected as describe in "Arms and Interventions", but for urine samples were used only the samples collected at times 0 (before the juice intake), 0-1h, 1-2h, 2-4h and at 24h after intake.
The plasma samples had their proteins precipitated with cold methanol, the metabolites were extracted, concentrated and the amino acids and organic acids were derivatized to became volatile and the samples were analyzed by GCMS.
For urine samples the procedures were similar.
The mass fragment profile of derivatized compounds were compared to a GCMS library.
|
1 month
|
|
Identification of anthocyanins in urine samples of 10 healthy volunteers by LCMS.
Lasso di tempo: 2 months
|
The blood and urine samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the anthocyanins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by LC-ESI-MSn (for phenolic acids and anthocyanins) the mass fragments were expressed in m/z.
|
2 months
|
|
Identification of phenolic acids in plasma and urine samples of 10 healthy volunteers by LCMS
Lasso di tempo: 2 months
|
The blood and urine samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the anthocyanins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by LC-ESI-MSn (for phenolic acids and anthocyanins) the mass fragments were expressed in m/z.
|
2 months
|
|
Identification of urolithins in urine samples of 10 healthy volunteers by LCMS
Lasso di tempo: 2 months
|
The urine samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the ellagitannins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by LC-Q-TOF (for urolithins), the mass fragments were expressed in m/z.
|
2 months
|
|
Quantification of anthocyanins in urine samples of 10 healthy volunteers by HPLC
Lasso di tempo: 2 months
|
The urine samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the anthocyanins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by HPLC, the results were expressed nmol/mol of creatinine for urine samples.
It was made to each volunteer, in each point of collection sample.
|
2 months
|
|
Quantification of urolithins in urine samples of 10 healthy volunteers by HPLC
Lasso di tempo: 2 months
|
The urine samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the ellagitannins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by HPLC, the results were expressed in mmol/mol of creatinine.
It was made to each volunteer, in each point of collection sample.
|
2 months
|
|
Antiproliferative activity of metabolites extracted from plasma of 10 healthy volunteers after grumixama juice intake
Lasso di tempo: 2 days
|
Plasma preparations were obtained by SPE extraction were dried and tested against breast cancer cells (MDA-MB 231) MDA-MB 231 cells were cultured in monolayer on Dulbecco Eagle modified culture medium supplemented with 10% fetal bovine serum, it was used 5x10-4 cells per well.
The cells were incubated in a humidified chamber including 5% CO2 at 37ºC into a confluence of approximately 80%.
Cells were further exposed to 200 mg/mL of plasma extract preparations and phenolic compound standards (PCA, VA, HA, C3G) at 0.25 and 25 mg/mL, and maintained at 37ºC, under an atmosphere of 5% CO2 for 48 hours.
Negative control was supplied with growth media and DMSO, and blank wells containing growth media only.
Cells were marked with CFSE, and fluorescence was measured by flow cytometer.
The results were expressed as % of proliferation inhibition.
|
2 days
|
|
Antiproliferative activity of metabolites extracted from urine of 10 healthy volunteers after grumixama juice intake
Lasso di tempo: 2 days
|
Urine preparations were obtained by SPE extraction were dried and tested against breast cancer cells (MDA-MB 231) MDA-MB 231 cells were cultured in monolayer on Dulbecco Eagle modified culture medium supplemented with 10% fetal bovine serum, it was used 5x10-4 cells per well.
The cells were incubated in a humidified chamber including 5% CO2 at 37ºC into a confluence of approximately 80%.
Cells were further exposed to 200 mg/mL of urine extract preparations and phenolic compound standards (PCA, VA, HA, C3G) at 0.25 and 25 mg/mL, and maintained at 37ºC, under an atmosphere of 5% CO2 for 48 hours.
Negative control was supplied with growth media and DMSO, and blank wells containing growth media only.
Cells were marked with CFSE, and fluorescence was measured by flow cytometer.
The results were expressed as % of proliferation inhibition
|
2 days
|
|
Quantification of amino acids identified by GCMS
Lasso di tempo: 1 month
|
Standards curves of the amino acids that changed significantly after grumixama juice intake were made by GCMS.
Through these standards curves the amino acids and organic acids were quantified and the results were expressed in mmol/μmol of creatinine for urine samples and mmol/mL of plasma.
|
1 month
|
|
Quantification of organic acids identified by GCMS
Lasso di tempo: 1 month
|
Standards curves of organic acids that changed significantly after grumixama juice intake were made by GCMS.
Through these standards curves the organic acids were quantified and the results were expressed in mmol/μmol of creatinine for urine samples and mmol/mL of plasma.
|
1 month
|
|
Quantification of phenolic acids in plasma samples of 10 healthy volunteers by HPLC
Lasso di tempo: 2 months
|
The blood samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the anthocyanins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by HPLC, the results were expressed in μmol/mL of plasma.
It was made to each volunteer, in each point of collection sample.
|
2 months
|
|
Quantification of phenolic acids in urine samples of 10 healthy volunteers by HPLC
Lasso di tempo: 2 months
|
The urine samples were collected in the times describe in "Arms and Interventions".
The samples were acidified and the anthocyanins metabolites were extracted by SPE column, these metabolites extracted were concentrated and analyzed by HPLC, the results were expressed in mmol/mol of creatinine for urine samples.
It was made to each volunteer, in each point of collection sample.
|
2 months
|
|
Pharmacokinetic parameters (AUC) of anthocyanins in urine of 10 healthy volunteers after intake of grumixama juice
Lasso di tempo: 1 month
|
Using the quantification results for each collection time was calculated the area under curve (AUC) of anthocyanins in urine (expressed in μmol/h).
|
1 month
|
|
Pharmacokinetic parameters (AUC) of phenolic acids in urine of 10 healthy volunteers after intake of grumixama juice
Lasso di tempo: 1 month
|
Using the quantification results for each collection time was calculated the area under curve (AUC) of phenolic acids in urine (expressed in mmol/h).
|
1 month
|
|
Pharmacokinetic parameters (AUC) of urolithins in urine of 10 healthy volunteers after intake of grumixama juice
Lasso di tempo: 1 month
|
Using the quantification results for each collection time was calculated the area under curve (AUC) of urolithins in urine (expressed in mmol/h).
|
1 month
|
|
Urine volume
Lasso di tempo: 1 day
|
The volume of each urine sample was measured in mL.
|
1 day
|
|
The total elimination of anthocyanins in urine of 10 healthy volunteers after intake of grumixama juice
Lasso di tempo: 1 month
|
The total elimination amount of anthocyanins was calculated using the urine volume and it was expressed in nmol.
|
1 month
|
|
The total elimination of phenolic acids in urine of 10 healthy volunteers after intake of grumixama juice
Lasso di tempo: 1 month
|
The total elimination amount of phenolic acids was calculated using the urine volume and it was expressed in µmol.
|
1 month
|
|
The total elimination of urolithins in urine of 10 healthy volunteers after intake of grumixama juice
Lasso di tempo: 1 month
|
The total elimination amount of urolithins was calculated using the urine volume and it was expressed in µmol.
|
1 month
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Normal blood glycemia values of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The glycemia was measured in 15 volunteers to evaluate if the glycemia values were acceptable.
The values were expressed in mg/dL.
|
1 day
|
|
Normal total cholesterol values of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The total cholesterol was measured in 15 volunteers to evaluate if the cholesterol values were acceptable.
The values were expressed in mg/dL.
|
1 day
|
|
Normal triglycerides values of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The triglycerides were measured in 15 volunteers to evaluate if the triglycerides values were acceptable.
The values were expressed in mg/dL.
|
1 day
|
|
Normal HDL values of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The HDL values were measured in 15 volunteers to evaluate if the HDL and LDL values were acceptable.
The values were expressed in mg/dL.
|
1 day
|
|
Similar weight of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The weight was measured in 15 volunteers to calculate the dose of juice to be give to the volunteers and also to calculate the BMI.
The results were expressed in Kg of body mass.
|
1 day
|
|
Similar height of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The height was measured in 15 volunteers to calculate the body index mass (BMI).
The results were expressed in meters (m).
|
1 day
|
|
Similar BMI of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The height was measured in 15 volunteers to calculate the body index mass (BMI).
The results were expressed in Kg/m2.
This assessment was made to check if the volunteers had a similar BMI.
|
1 day
|
|
Normal LDL values of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The LDL values were measured in 15 volunteers to evaluate if the HDL and LDL values were acceptable.
The values were expressed in mg/dL.
|
1 day
|
|
Normal serum creatinine of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The serum creatinine values were measured in 15 volunteers to evaluate if the values were acceptable.
The values were expressed in mg/dL.
|
1 day
|
|
Alanine aminotransferase measures in serum samples of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The alanine aminotransferase was measured in the serum of 15 volunteers to evaluate if the values were acceptable.
The values were expressed in U/L.
|
1 day
|
|
The aspartate transaminase measures in serum samples of 15 volunteers before juice intake
Lasso di tempo: 1 day
|
The aspartate transaminase was measured in the serum of 15 volunteers to evaluate if the values were acceptable.
The values were expressed in U/L.
|
1 day
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Luciane L. Teixeira, MS, University of Sao Paulo
- Cattedra di studio: Neuza M. Aymoto Hassimotto, PhD, University of Sao Paulo
- Cattedra di studio: Franco M. Lajolo, PhD, University of Sao Paulo
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Pubblicazioni generali
- Flores G, Dastmalchi K, Paulino S, Whalen K, Dabo AJ, Reynertson KA, Foronjy RF, D'Armiento JM, Kennelly EJ. Anthocyanins from Eugenia brasiliensis edible fruits as potential therapeutics for COPD treatment. Food Chem. 2012 Oct 1;134(3):1256-62. doi: 10.1016/j.foodchem.2012.01.086. Epub 2012 Feb 18.
- Reynertson KA, Yang H, Jiang B, Basile MJ, Kennelly EJ. Quantitative analysis of antiradical phenolic constituents from fourteen edible Myrtaceae fruits. Food Chem. 2008 Aug 15;109(4):883-890. doi: 10.1016/j.foodchem.2008.01.021.
- Teixeira Lde L, Bertoldi FC, Lajolo FM, Hassimotto NM. Identification of Ellagitannins and Flavonoids from Eugenia brasilienses Lam. (Grumixama) by HPLC-ESI-MS/MS. J Agric Food Chem. 2015 Jun 10;63(22):5417-27. doi: 10.1021/acs.jafc.5b01195. Epub 2015 Jun 2.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 marzo 2014
Completamento primario (Effettivo)
1 agosto 2014
Completamento dello studio (Effettivo)
1 marzo 2016
Date di iscrizione allo studio
Primo inviato
2 aprile 2016
Primo inviato che soddisfa i criteri di controllo qualità
30 maggio 2016
Primo Inserito (Stima)
6 giugno 2016
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
14 giugno 2016
Ultimo aggiornamento inviato che soddisfa i criteri QC
13 giugno 2016
Ultimo verificato
1 maggio 2016
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 17449613.8.0000.0067
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .